This bill proposes to amend the Arizona Revised Statutes by adding a new chapter that addresses the sale of essential off-patent or generic drugs, specifically targeting price gouging. It defines "essential off-patent or generic drug" and "price gouging," establishing criteria for what constitutes an unconscionable increase in drug prices. The bill prohibits manufacturers and wholesale distributors from engaging in price gouging and outlines the conditions under which price increases may be justified. It also mandates that the state medical assistance program notify the attorney general of significant price increases and provides a framework for the attorney general to investigate and take action against violations.

Additionally, the bill grants the attorney general the authority to compel manufacturers to provide detailed cost information and allows for court orders to restrain violations, restore funds to consumers, and impose civil penalties. It emphasizes the confidentiality of information provided by manufacturers during investigations and clarifies that defendants cannot claim a lack of direct consumer interaction as a defense in legal actions. Overall, the bill aims to enhance consumer protection in the pharmaceutical market by regulating the pricing of essential medications.